[1] Dose-escalation studies, such as a 12-week trial on gradual titration, revealed that beginning at lower doses (e.g., 4 mg) and slowly increasing to therapeutic levels significantly reduced the incidence of nausea, vomiting, and diarrhoea
Slow structural repair can slow down cell turnover 1
Atrial fibrillation: The difference between men and women
Flow-cytometry gating strategy for LGR5 hi stem cells, LGR5 low progenitor cells and Paneth cells from control and KD-fed mice, shown in Extended Data Fig
The no DAC form lacks the Drug Affinity Complex modification, which in other versions allows prolonged binding to albumin and extended activity
He explains that the studys primary end point a composite of cardiovascular death, MI or stroke was chosen because it was the end point of the REWIND trial that supported dulaglutides regulatory approval for reduction of major adverse cardiovascular events